FGFR inhibitor resistance in cholangiocarcinoma: current understanding and future directions

Expert Opin Pharmacother. 2023 Sep-Dec;24(17):1833-1837. doi: 10.1080/14656566.2023.2259802. Epub 2023 Sep 14.
No abstract available

Keywords: FGFR; biliary tract cancer; biomarkers; precision medicine; resistance mechanisms; targeted therapy.

Publication types

  • Editorial

MeSH terms

  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic
  • Cholangiocarcinoma* / drug therapy
  • Humans
  • Molecular Targeted Therapy